S. Meredith

International survey on high‐ and low‐dose synacthen test and assessment of accuracy in preparing low‐dose synacthen

N. Krone, Alexandra S. Cross, E. Helen Kemp, 2018, Clinical endocrinology.

Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.

A. Ullrich, G. Mcmahon, E. Hersh, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Targeting hypoxia in the treatment of small cell lung cancer.

A. White, S. Meredith, K. J. Williams, 2014, Lung cancer.

Cushing syndrome in a child due to pro-opiomelanocortin (POMC) secretion from a yolk sac tumor.

M. Dattani, N. Sebire, O. Slater, 2017, European journal of endocrinology.

Novel carbonic anhydrase IX‐targeted therapy enhances the anti‐tumour effects of cisplatin in small cell lung cancer

C. Supuran, B. Telfer, K. Williams, 2018, International journal of cancer.

Glucocorticoid receptor-mediated apoptosis in small-cell lung cancer requires interaction with BCL2.

G. Schlossmacher, A. Davies, A. White, 2013, Endocrine-related cancer.

Phenotypic heterogeneity in small cell lung cancer models in vitro and in vivo

S. Meredith, Suzanne Meredith, 2013 .

Biomarkers for small cell lung cancer: neuroendocrine, epithelial and circulating tumour cells.

C. Dive, F. Blackhall, J. Hou, 2012, Lung cancer.

Irradiation Decreases the Neuroendocrine Biomarker Pro-Opiomelanocortin in Small Cell Lung Cancer Cells In Vitro and In Vivo

K. Williams, Anne White, M. Babur, 2016, PloS one.

Neuroendocrine and epithelial phenotypes in small-cell lung cancer: implications for metastasis and survival in patients

K. Williams, C. Dive, F. Blackhall, 2013, British Journal of Cancer.